We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

104 hedge funds and large institutions have $1.02B invested in Heron Therapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

667% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $1.58M

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

13% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 31

6% more capital invested

Capital invested by funds: $964M → $1.02B (+$59.8M)

0% more funds holding

Funds holding: 104 → 104 (0)

12.53% less ownership

Funds ownership: 129.64% → 117.12% (-13%)

Holders
104
Holders Change
–
Holders Change %
0%
% of All Funds
2.59%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
14
Increased
35
Reduced
31
Closed
12
Calls
$12.1M
Puts
$1.58M
Net Calls
+$10.6M
Net Calls Change
-$11.9M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$5.18M
2
Millennium Management
Millennium Management
New York
+$3.15M
3
RCMNY
Rubric Capital Management (New York)
New York
+$3.14M
4
State Street
State Street
Massachusetts
+$2.88M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.87M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$46.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$17.6M
3
BC
Broadfin Capital
New York
-$15.1M
4
TCP
Tourbillon Capital Partners
New York
-$11.8M
5
Citigroup
Citigroup
New York
-$5.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$5.97M +$3.15M +201,097 +119%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$5.41M -$3.69M -235,417 -41%
PA
28
Perceptive Advisors
New York
$5.33M +$5.18M +330,000 New
Goldman Sachs
29
Goldman Sachs
New York
$4.46M -$2.23M -142,377 -34%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$3.88M +$2.87M +182,875 +319%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.29M -$13.5K -862 -0.4%
Citadel Advisors
32
Citadel Advisors
Florida
$2.99M -$17.6M -1,122,782 -86%
Charles Schwab
33
Charles Schwab
California
$2.6M -$147K -9,356 -5%
CIP
34
Chartwell Investment Partners
Pennsylvania
$2.34M +$2.27M +144,947 New
GC
35
Guggenheim Capital
Illinois
$2.32M +$418K +26,657 +23%
Wells Fargo
36
Wells Fargo
California
$2.11M +$1.37M +87,212 +202%
TCIM
37
TIAA CREF Investment Management
New York
$1.98M +$16.1K +1,025 +0.8%
Allianz Asset Management
38
Allianz Asset Management
Germany
$1.77M +$800 +51 +0%
Fisher Asset Management
39
Fisher Asset Management
Washington
$1.62M +$1.57M +100,364 New
CWG
40
C WorldWide Group
Denmark
$1.61M +$1.57M +100,000 New
ACM
41
Atika Capital Management
New York
$1.45M +$188K +12,000 +15%
TA
42
Teachers Advisors
New York
$1.34M – – –
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.27M – – –
BGIM
44
Brandywine Global Investment Management
Pennsylvania
$1.26M -$41.4K -2,637 -3%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.17M -$124K -7,921 -10%
Morgan Stanley
46
Morgan Stanley
New York
$1.16M -$455K -29,030 -29%
BRWA
47
B. Riley Wealth Advisors
Florida
$1.11M +$340K +21,700 +46%
RA
48
Royce & Associates
New York
$1.09M +$157K +10,000 +17%
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.06M – – –
ACM
50
Asymmetry Capital Management
California
$1.02M +$988K +62,962 New
1
2
3 4 5

HRTX Hedge Fund Activity: Q3 2017 in Review

104 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2017, worth a combined $1.02B — up 6.2% from $964M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new HRTX positions and 12 closed out — a net gain of 2 holders — while 35 added to existing stakes and 31 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $5.18M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $46.3M sold.

  • 104 institutional investors held Heron Therapeutics (HRTX) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $1.02B of Heron Therapeutics stock for Q3 2017, up 6.2% quarter-over-quarter.
  • 14 funds opened new Heron Therapeutics positions in Q3 2017 and 12 closed out, a net change of +2 holders.
  • The largest Heron Therapeutics buyer in Q3 2017 was Perceptive Advisors, an estimated $5.18M added.
  • The largest Heron Therapeutics seller in Q3 2017 was PFM Health Sciences, an estimated $46.3M sold.

Based on aggregated 13F filings for Q3 2017.